Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance
February 2019
Author(s): Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, et al
Details: J Hepatol. 2019
NIHR Acknowledged: Yes
People
Photo | Name | Bio |
---|